Orsythia
Product Images NDC 50090-1380

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Orsythia (NDC 50090-1380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500901380)

Packaging label of Orsythia by A-S Medication Solutions displaying product number 6442-0 and NDC 50090-1380-0. It contains one blister pack with 28 tablets, each tablet containing 0.15 mg ethinyl estradiol and 0.015 mg levonorgestrel. Storage instructions specify 46-77 degrees Fahrenheit. The label includes a barcode and distributor address in Spokane, WA.*

FDA Label Image

This Is The Chemical Image Of Levonorgestrel And Ethinyl Estradiol. (Orsythia 1)

Chemical structures of the active ingredients Levonorgestrel and Ethinyl Estradiol are shown. Each structure includes a molecular formula and molecular weight: Levonorgestrel (C21H28O2, MW 312.45) and Ethinyl Estradiol (C20H24O2, MW 296.40). Both are steroidal compounds depicted in black and white line drawings.*

FDA Label Image

Figure I: Mean (se) Levonorgestrel And Ethinyl Estradiol Serum Concentrations In 22 Subjects Receiving Levonorgestrel And Ethinyl Estradiol (100 Mcg Levonorgestrel And 20 Mcg Ethinyl Estradiol) (Orsythia 2)

A figure showing mean serum concentration (with standard error bars) of Levonorgestrel and Ethinyl Estradiol over 72 hours. The left graph depicts Levonorgestrel levels, and the right graph shows Ethinyl Estradiol levels, both measured at Days 1, 6, and 21 from 22 subjects receiving 100 mcg Levonorgestrel and 20 mcg Ethinyl Estradiol.*

FDA Label Image

This Is A Figure Of Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral-conraception Use. (Orsythia 3)

A bar chart comparing four groups—ever-users (nonsmokers and smokers) and controls (nonsmokers and smokers)—across age ranges 15-24, 25-34, 35-44, and 45+. The vertical axis shows a numeric scale from 0 to 200, with values increasing significantly for ever-users (smokers) in the 45+ age group.*

FDA Label Image

This Is An Image Of Package One. (Orsythia 4)

An instructional diagram for Orsythia tablets showing a 4-week pill pack layout with days of the week and weeks numbered. It guides users to start on Sunday or Day 1 of their period, taking pink tablets first in the indicated left-to-right weekly direction, including the active ingredients levonorgestrel 0.1 mg and ethinyl estradiol 0.02 mg.*

FDA Label Image

This Is An Image Of Package One. (Orsythia 5)

An instructional diagram for Orsythia oral contraceptive tablets showing a weekly pill schedule. It includes a day label strip for Sunday starters and day 1 starters, with pill circles arranged by week and day from left to right. Text instructs to take pink tablets first, lists active ingredients levonorgestrel (0.1 mg) and ethinyl estradiol (0.02 mg), and indicates the direction to take pills each week from left to right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.